市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Distribution (US) | 混合的 | 看跌 |
| Medical Distribution (全球的) | 混合的 | 看跌 | |
| 股票 | 111, Inc. | - | - |
AIStockmoo 评分
| 分析师共识 | 0.0 |
| 内部交易活动 | NA |
| 价格波动 | -0.5 |
| 技术平均移动指标 | -1.0 |
| 技术振荡指标 | -0.5 |
| 平均 | -0.50 |
|
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People’s Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment. |
|
| 部门 | Healthcare |
| 行业 | Medical Distribution |
| 内部持股比例 | 15.84% |
| 机构持股比例 | 23.69% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Napean Trading & Investment Co (Singapore) Pte Ltd | 31 Dec 2024 | 39,316 |
| Railway Pension Investments Ltd | 31 Dec 2024 | 25,723 |
| Parafestas Anastasios | 31 Dec 2024 | 13,616 |
| Serenus Wealth Advisors, Llc | 31 Dec 2024 | 4,563 |
该时间范围内无数据。
该时间范围内无数据。
| 日期 | 类型 | 细节 |
|---|---|---|
| 19 Jun 2025 | 公告 | 111, Inc. Announces First Quarter 2025 Unaudited Financial Results |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合